{"id":"W3148345241","doi":"10.1200/jco.20.03639","title":"Palbociclib for Residual High-Risk Invasive HR-Positive and HER2-Negative Early Breast Cancer—The Penelope-B Trial","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":324,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Palbociclib; Oncology; Internal medicine; Lapatinib; Taxane; Breast cancer; Letrozole; Estrogen receptor; Hormone receptor; Aromatase inhibitor; Gynecology; Tamoxifen; Cancer; Trastuzumab; Metastatic breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00223858,0.0002038958,0.001622408,0.00005865182,0.0001544877,0.000024411,0.0001706058,0.0003489904,0.0001752961],"category_scores_gemma":[0.006753688,0.0001293291,0.000424999,0.0001609852,0.000638083,0.000158922,0.00009182459,0.001237898,0.000004038528],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002307514,"about_ca_system_score_gemma":0.004112468,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000387713,"about_ca_topic_score_gemma":0.001135228,"domain_scores_codex":[0.9962011,0.001011183,0.00177685,0.0003225135,0.0003736487,0.0003147351],"domain_scores_gemma":[0.9828402,0.0127425,0.002197641,0.0002122551,0.001658152,0.0003492074],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.3961377,0.001294391,0.03206012,0.00005085299,0.002996776,0.0008638207,0.001902809,0.0000314346,0.0002929161,0.0004960574,0.002871875,0.5610013],"study_design_scores_gemma":[0.1734399,0.01989647,0.7739491,0.0003400675,0.001539352,0.001432862,0.001384064,0.00000641762,0.001353788,0.01054469,0.01590051,0.0002128026],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9484771,0.001130731,0.0002923344,0.04723077,0.001822373,0.0006586547,0.0001598968,0.000009022399,0.0002191134],"genre_scores_gemma":[0.9764476,0.0033048,0.007187895,0.005067399,0.007217272,0.00005826026,0.000004953425,0.00004160667,0.0006701474],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.741889,"threshold_uncertainty_score":0.8085283,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08584686499972378,"score_gpt":0.4566029099254679,"score_spread":0.3707560449257442,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}